"Le Centre Hospitalier de Béthune Beuvry est un hôpital de proximité et de recours qui propose une offre de soins complète : urgences, consultations, examens, interventions chirurgicales, etc. ainsi que des prises en charge d’excellence en médecine, chirurgie et en cancérologie."

During the past decade, CH Béthune conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 1 clinical trials were completed, i.e. on average, 3.6% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH Béthune" #1 sponsor was "University Hospital, Lille" with 11 trials, followed by "Centre Oscar Lambret" with 3 trials sponsored, "Centre Hospitalier Universitaire, Amiens" with 2 trials sponsored, "Nantes University Hospital" with 2 trials sponsored and "Tourcoing Hospital" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH Béthune" #1 collaborator was "Ministry of Health, France" with 3 trials as a collaborator, "Assistance Publique Hopitaux De Marseille" with 2 trials as a collaborator, "Laboratoire français de Fractionnement et de Biotechnologies" with 2 trials as a collaborator, "Région Nord-Pas de Calais, France" with 2 trials as a collaborator and "Agence Nationale de sécurité du Médicament" with 1 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "CH Béthune" are "Cancer" (2 trials), "Acute Circulatory Failure" (1 trials), "Acute Respiratory Distress Syndrome" (1 trials), "Acute Respiratory Failure" (1 trials) and "Alcoholic Hepatitis" (1 trials). Many other conditions were trialed in "CH Béthune" in a lesser frequency.

Most popular intervention types in "CH Béthune" are "Drug" (11 trials), "Other" (8 trials), "Device" (5 trials), "Procedure" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "placebo" (2 trials), "CEFAR Primo Pro (TENS device)" (1 trials), "Caffeine" (1 trials) and "Center respiratory rehabilitation" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH Béthune" are 32 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "CH Béthune". 1 are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in CH Béthune, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in CH Béthune, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".